Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 99: 71-80, 2005. First published March 17, 2005; doi:10.1152/japplphysiol.00448.2004
8750-7587/05 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
99/1/71    most recent
00448.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yimlamai, T.
Right arrow Articles by Park, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yimlamai, T.
Right arrow Articles by Park, S.

Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway

Tossaporn Yimlamai,1 Stephen L. Dodd,1 Stephen E. Borst,1,2 and Sooyeon Park1

1Department of Applied Physiology and Kinesiology, University of Florida, Gainesville; and 2Geriatric, Research, Education, and Clinical Center, Malcom Randall Veterans’ Affairs Medical Center, Gainesville, Florida

Submitted 28 April 2004 ; accepted in final form 15 March 2005

The ubiquitin-proteasome pathway is primarily responsible for myofibrillar protein degradation during hindlimb unweighting (HU). {beta}-Adrenergic agonists such as clenbuterol (CB) induce muscle hypertrophy and attenuate muscle atrophy due to disuse or inactivity. However, the molecular mechanism by which CB exerts these effects remains poorly understood. The aims of this study were to investigate whether CB attenuates HU-induced muscle atrophy through an inhibition of the ubiquitin-proteasome pathway and whether insulin-like growth factor I (IGF-I) mediates this inhibition. Rats were randomized to the following groups: weight-bearing control, 14-day CB-treated, 14-day HU, and CB + HU. HU-induced atrophy was associated with increased proteolysis and upregulation of components of the ubiquitin-proteasome pathway (ubiquitin conjugates, ubiquitin conjugating enzyme E2-14kDa, and 20S proteasome activity). Upregulation of the ubiquitin proteasome occurred in all muscles tested but was more pronounced in muscles composed primarily of slow-twitch fibers (soleus) than in fast-twitch muscles (plantaris and tibialis anterior). Although CB induced hypertrophy in all muscles, CB attenuated the HU-induced atrophy and reduced ubiquitin conjugates only in the fast plantaris and tibialis anterior and not in the slow soleus muscle. CB did not elevate IGF-I protein content in either of the muscles examined. These results suggest that CB induces hypertrophy and alleviates HU-induced atrophy, particularly in the fast muscles, at least in part through a muscle-specific inhibition of the ubiquitin-proteasome pathway and that these effects are not mediated by the local production of IGF-I in skeletal muscle.

hindlimb unweighting; protein degradation; insulin-like growth factor 1


Address for reprint requests and other correspondence: S. L. Dodd, PO Box 118205, Univ. of Florida, Gainesville, FL 32611 (E-mail: sdodd{at}hhp.ufl.edu)




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
F. Kawano, Y. Matsuoka, Y. Oke, Y. Higo, M. Terada, X. D. Wang, N. Nakai, H. Fukuda, S. Imajoh-Ohmi, and Y. Ohira
Role(s) of nucleoli and phosphorylation of ribosomal protein S6 and/or HSP27 in the regulation of muscle mass
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C35 - C44.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
I. J. Smith and S. L. Dodd
Muscle: Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle
Exp Physiol, May 1, 2007; 92(3): 561 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. M. Baviera, N. M. Zanon, L. C. Carvalho Navegantes, R. H. Migliorini, and I. d. C. Kettelhut
Pentoxifylline inhibits Ca2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E702 - E708.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
W. O. Kline, F. J. Panaro, H. Yang, and S. C. Bodine
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
J Appl Physiol, February 1, 2007; 102(2): 740 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. R. Judge, A. Koncarevic, R. B. Hunter, H.-C. Liou, R. W. Jackman, and S. C. Kandarian
Role for I{kappa}B{alpha}, but not c-Rel, in skeletal muscle atrophy
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C372 - C382.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. E. Dupont-Versteegden, J. D. Fluckey, M. Knox, D. Gaddy, and C. A. Peterson
Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult rats
J Appl Physiol, July 1, 2006; 101(1): 202 - 212.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.